A study led by Queen Mary University of London described a viral protein strategy to overcome cellular restrictions on self-amplifying RNA (saRNA). In a Nature Communications paper, adding the Nodamura virus B2 protein (NoV B2)—known to suppress RNA interference—reduced the extent of saRNA restriction and increased the amount of intended protein produced in both stem cells and regular cells, while preserving immune stimulation.